User: Guest  Login
Title:

Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion.

Document type:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't; Article
Author(s):
Augustin, Albert J; Holz, Frank G; Haritoglou, Christos; Mayer, Wolfgang J; Bopp, Silvia; Scheuerle, Alexander F; Maier, Matthias; Sekundo, Walter; Sandner, Dirk; Shirlaw, Andrew; Hattenbach, Lars-Olof
Abstract:
To retrospectively evaluate the re-injection interval, efficacy and safety of dexamethasone (DEX) intravitreal implant 0.7 mg in the treatment of macular oedema (ME) due to retinal vein occlusion (RVO) in Germany in 2009-2012.Retrospective, multicentre, anonymised observational study of data collected from the first DEX implant 0.7 mg injection through 3-6 months following the last injection. Data were included if the patient was >18 years old, had a diagnosis of ME secondary to branch or centra...     »
Journal title abbreviation:
Ophthalmologica
Year:
2015
Journal volume:
233
Journal issue:
1
Pages contribution:
18-26
Language:
eng
Fulltext / DOI:
doi:10.1159/000368840
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/25503473
Print-ISSN:
0030-3755
TUM Institution:
Klinik und Poliklinik für Augenheilkunde
 BibTeX